Malaria study suggests drugs should target female parasites
Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease.
Nov 28, 2012
0
0
Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease.
Nov 28, 2012
0
0
(Phys.org)—Johns Hopkins researchers have uncovered a protein "partner" commonly used by breast cancer cells to unlock genes needed for spreading the disease around the body. A report on the discovery, published November ...
Nov 25, 2012
0
0
(Medical Xpress)—Researchers at the University of Georgia will soon begin a study designed to identify new ways of determining treatment efficacy in Chagas disease, a potentially fatal tropical disease that infects approximately ...
Nov 22, 2012
0
0
(Medical Xpress)—Drugs for psychiatric disorders such as depression and schizophrenia often require weeks to take full effect. "What takes so long?" has formed one of psychiatry's most stubborn mysteries. Now a fresh look ...
Nov 21, 2012
2
0
Pluripotent stem cells are nature's double-edged sword. Because they can develop into a dizzying variety of cell types and tissues, they are a potentially invaluable therapeutic resource. However, that same developmental ...
Nov 19, 2012
0
0
Researchers using a new approach to identifying genes associated with depression have found that variants in a group of genes involved in transmission of signals by the neurotransmitter glutamate appear to increase the risk ...
Nov 13, 2012
0
0
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through ...
Nov 13, 2012
0
0
(Medical Xpress)—Researchers in the Life Sciences Institute at the University of Michigan have discovered how a particular type of virus hides and protects its genetic information from the immune system, a design that allows ...
Nov 7, 2012
0
0
A drug commonly used in treating breast cancer could have far wider benefits, offering a new way of preventing cancers spreading through the body, according to a University of Leeds-led study.
Nov 6, 2012
0
0
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts ...
Nov 1, 2012
0
0